SEC Form 4 · accession 0001645627-18-000065
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 9, 2018
Accepted (ET)
Oct 16, 2018 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 9, 2018 | P | 1,000 | $0.0488 | A | 26,011,898 | D | |
| Common Stock | Oct 10, 2018 | P | 2,000 | $0.05 | A | 26,013,898 | D | |
| Common Stock | Oct 10, 2018 | P | 2,000 | $0.0505 | A | 26,015,898 | D | |
| Common Stock | Oct 10, 2018 | P | 1,000 | $0.0505 | A | 26,016,898 | D | |
| Common Stock | Oct 10, 2018 | P | 1,000 | $0.0505 | A | 26,017,898 | D | |
| Common Stock | Oct 10, 2018 | P | 1,000 | $0.0504 | A | 26,018,898 | D | |
| Common Stock | Oct 11, 2018 | P | 1,000 | $0.0496 | A | 26,019,898 | D | |
| Common Stock | Oct 11, 2018 | P | 1,000 | $0.0499 | A | 26,020,898 | D | |
| Common Stock | Oct 11, 2018 | P | 2,000 | $0.0499 | A | 26,022,898 | D | |
| Common Stock | Oct 12, 2018 | P | 2,000 | $0.0485 | A | 26,024,898 | D | |
| Common Stock | Oct 12, 2018 | P | 1,000 | $0.0478 | A | 26,025,898 | D | |
| Common Stock | Oct 12, 2018 | P | 1,000 | $0.0472 | A | 26,026,898 | D | |
| Common Stock | Oct 12, 2018 | P | 1,000 | $0.0472 | A | 26,027,898 | D | |
| Common Stock | Oct 12, 2018 | P | 1,000 | $0.0487 | A | 26,028,898 | D |
Table II — derivative securities
No Table II lines on this filing.